Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

156 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis.
Corrao G, Marvaso G, Mastroleo F, Biffi A, Pellegrini G, Minari S, Vincini MG, Zaffaroni M, Zerini D, Volpe S, Gaito S, Mazzola GC, Bergamaschi L, Cattani F, Petralia G, Musi G, Ceci F, De Cobelli O, Orecchia R, Alterio D, Jereczek-Fossa BA. Corrao G, et al. Among authors: marvaso g. Radiother Oncol. 2024 Jun;195:110264. doi: 10.1016/j.radonc.2024.110264. Epub 2024 Mar 30. Radiother Oncol. 2024. PMID: 38561122
Oligorecurrent Prostate Cancer and Stereotactic Body Radiotherapy: Where Are We Now? A Systematic Review and Meta-analysis of Prospective Studies.
Marvaso G, Volpe S, Pepa M, Augugliaro M, Corrao G, Biffi A, Zaffaroni M, Bergamaschi L, La Fauci FM, Mistretta FA, Luzzago S, Cattani F, Musi G, Petralia G, Pravettoni G, De Cobelli O, Orecchia R, Jereczek-Fossa BA. Marvaso G, et al. Eur Urol Open Sci. 2021 Mar 16;27:19-28. doi: 10.1016/j.euros.2021.02.008. eCollection 2021 May. Eur Urol Open Sci. 2021. PMID: 34337513 Free PMC article. Review.
Short-term high precision radiotherapy for early prostate cancer with concomitant boost to the dominant lesion: ad interim analysis and preliminary results of Phase II trial AIRC-IG-13218.
Timon G, Ciardo D, Bazani A, Marvaso G, Riva G, Volpe S, Rojas DP, Renne G, Petralia G, Zerini D, Fodor C, Dicuonzo S, Maestri D, Pansini F, Cambria R, Cattani F, Golino F, Scroffi V, De Lorenzo D, De Cobelli O, Orecchia R, Jereczek-Fossa BA. Timon G, et al. Among authors: marvaso g. Br J Radiol. 2018 Sep;91(1089):20160725. doi: 10.1259/bjr.20160725. Epub 2018 May 23. Br J Radiol. 2018. PMID: 29750539 Free PMC article. Clinical Trial.
A global Unified Dosimetry Index (gUDI) to evaluate simultaneous integrated boost radiotherapy plans in prostate cancer.
Mambretti M, Romanò C, Marvaso G, Comi S, Cambria R, Ciardo D, Emiro F, Fodor C, Zerini D, Riva G, Petralia G, De Cobelli O, Orecchia R, Cattani F, Jereczek-Fossa BA. Mambretti M, et al. Among authors: marvaso g. Radiother Oncol. 2018 Aug;128(2):315-320. doi: 10.1016/j.radonc.2018.06.002. Epub 2018 Jun 23. Radiother Oncol. 2018. PMID: 29945720
Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT).
Jereczek-Fossa BA, Rojas DP, Zerini D, Fodor C, Viola A, Fanetti G, Volpe S, Luraschi R, Bazani A, Rondi E, Cattani F, Vavassori A, Garibaldi C, Alessi S, Pricolo P, Petralia G, Cozzi G, De Cobelli O, Musi G, Orecchia R, Marvaso G, Ciardo D. Jereczek-Fossa BA, et al. Among authors: marvaso g. Br J Radiol. 2019 Feb;92(1094):20180494. doi: 10.1259/bjr.20180494. Epub 2018 Nov 9. Br J Radiol. 2019. PMID: 30379566 Free PMC article.
Ductal carcinoma in situ and intraoperative partial breast irradiation: Who are the best candidates? Long-term outcome of a single institution series.
Leonardi MC, Corrao G, Frassoni S, Vingiani A, Dicuonzo S, Lazzeroni M, Fodor C, Morra A, Gerardi MA, Rojas DP, Dell'Acqua V, Marvaso G, Bassi FD, Galimberti VE, Veronesi P, Miglietta E, Cattani F, Zurrida S, Bagnardi V, Viale G, Orecchia R, Jereczek-Fossa BA. Leonardi MC, et al. Among authors: marvaso g. Radiother Oncol. 2019 Apr;133:68-76. doi: 10.1016/j.radonc.2018.12.030. Epub 2019 Jan 17. Radiother Oncol. 2019. PMID: 30935584
Comparison of Outcomes and Toxicity Between Extreme and Moderate Radiation Therapy Hypofractionation in Localized Prostate Cancer: A Propensity Score Analysis.
Marvaso G, Ciardo D, Gandini S, Riva G, Frigo E, Volpe S, Fodor C, Zerini D, Rojas DP, Comi S, Cambria R, Cattani F, Musi G, De Cobelli O, Orecchia R, Jereczek-Fossa BA. Marvaso G, et al. Int J Radiat Oncol Biol Phys. 2019 Nov 15;105(4):735-744. doi: 10.1016/j.ijrobp.2019.07.027. Epub 2019 Aug 1. Int J Radiat Oncol Biol Phys. 2019. PMID: 31377161
Modern radiotherapy for head and neck cancer.
Alterio D, Marvaso G, Ferrari A, Volpe S, Orecchia R, Jereczek-Fossa BA. Alterio D, et al. Among authors: marvaso g. Semin Oncol. 2019 Jun;46(3):233-245. doi: 10.1053/j.seminoncol.2019.07.002. Epub 2019 Jul 26. Semin Oncol. 2019. PMID: 31378376 Review.
156 results